Discover · sciam.com

No picture published by sciam.com

Your Next Pain Prescription Could Come without Addiction Risk

60-Second Science sciam.com

This is what was read here when it was published. Scientific American no longer carries it in what it publishes now.

The Food and Drug Administration has granted priority review to suzetrigine, a novel painkiller. It’s part of a new class of medications that could provide relief to those with chronic pain. The drugs target sodium channels on nerve cells, stopping pain signaling at the periphery. Journalist Marla Broadfoot explains the biology of aches and pains and the reasons it is so challenging to develop well-tolerated medications for pain.

New Painkiller Could Bring Relief to Millions—Without Addiction Risk

More ways to use this
Open on another device
Scan this QR code to open the same public page

Scan to open this page. Your saved notes and account access are not included.

Download QR code

Open the page link

Names and references

  1. Risk — person

Named in it

Keep going

Each of these is read from what this estate already kept: the feed a piece came through, the publisher behind it, the credits and topics the publisher printed. None of it is a recommendation, an identity or a record kept anywhere else.

Also from 60-Second Science

  1. Cover Story: The End of Math as We Know ItScientific American sciam.com
  2. A Roman-era frog whodunit and more science surprisesScientific American sciam.com
  3. Did I stutter?Scientific American sciam.com
  4. Could this be the strongest El Niño in 1,000 years?Scientific American sciam.com
  5. From Farm Myths to Modern Agriculture [Sponsored]Scientific American sciam.com
  6. Mystery cat farts, measles and malicious cyberattacksScientific American sciam.com